OSCR

AETA peptide contributes to Alzheimer's disease signature of synapse dysfunction.

Overview

Authors: Jade Dunot1, Carine Gandin1, Marin Truchi1, Giulia Pirro1, Sébastien Moreno1, Agathe Launay2, Benjamin Azoulay1, Hugo Landra1,3, Sandy Ma Yishan1,3, Luc Buée2, Kevin Lebrigand1, Paula A. Pousinha1, David Blum2, Bernard Mari1, Ingrid Bethus1, Michael Willem4, Hélène Marie1
  1. Université Côte d’Azur, CNRS, INSERM, Institut de Pharmacologie Moléculaire et Cellulaire,Valbonne, France
  2. Univ. Lille, INSERM, CHU Lille, UMR-S1172 LilNCog-Lille Neuroscience and Cognition,Lille, France
  3. Munich Cluster for Systems Neurology (SyNergy),Munich, Germany
  4. Division of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München,Munich, Germany
Journal: Acta neuropathologica, volume 151, issue 1, article 65
Dates: received 24 November 2025; accepted 13 May 2026; published online 3 June 2026; in print 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1007/s00401-026-03033-2 · PMID 42237024 · PMCID PMC13233929 · OpenAlex W7163318344
Open access: hybrid, a free copy (OpenAlex)
Categories: human (organism), mouse (organism), Alzheimer's / dementia (population), cellular / molecular (subfield)
Methods: Single-unit activity, calcium imaging
Keywords: Synapse, Hippocampus, Memory, Alzheimer’s disease, Amyloid precursor protein
MeSH: Alzheimer Disease*, Amyloid beta-Protein Precursor*, Hippocampus*, Synapses*, Animals, Brain, Disease Models, Animal, Female, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Transgenic, Microglia, Neurons (* major topic)
Topic: Alzheimer's disease research and treatments (Cellular and Molecular Neuroscience, Neuroscience), according to OpenAlex
Funding: Agence Nationale de la Recherche (ANR-15-IDEX-01, ANR-21-ESRE-0052, ANR-10-INBS-09-02, ANR-10-INBS-09-03, ANR-21-CE16-0032 APPYSYNAPSE); fondation pour la recherche médicale (ECO202106013670); fondation vaincre alzheimer (FR-24054T); French Association France Alzheimer (AAP SM 2018 Dossier 1795 and APP PFA 2024 Dossier 6479); French Fondation Alzheimer ((AAP 2015 AETAPHYS); Flag ERA JTC 2019 (MILEDI Project)
Citations: not cited yet (Europe PMC); 52 references in the paper

Abstract

Alzheimer’s disease (AD), the leading cause of dementia, is characterized by early synaptic dysfunction that precedes overt cognitive decline. While amyloid-β and Tau remain central to AD pathogenesis, molecular triggers of synapse weakening remain unclear. Here, we investigated AETA, a novel brain-secreted peptide derived from amyloid precursor protein (APP), as a potential mediator of synapse dysfunction in AD. We previously identified AETA as a unique modulator of NMDA receptor activity in the healthy brain; however, its role in AD etiology was yet to be explored. Post-mortem analyses of human hippocampal and prefrontal cortex tissues revealed significantly elevated AETA levels in AD patients, particularly in females. To further explore the contribution of AETA to AD synaptic pathology, we analyzed a new mouse model, the AETA-m mouse, exhibiting chronically increased brain AETA expression. Hippocampi of female AETA-m mice displayed an increase in the number of astrocyte and microglia, but no overt neuroinflammation. RNA sequencing of female AETA-m hippocampi revealed alterations in synaptic gene expression that closely paralleled those observed in vulnerable human AD brain regions, most notably in the hippocampus. These two phenotypes were absent in males. Functionally, hippocampal neurons from AETA-m mice displayed impaired NMDA receptor signaling, dendritic spine loss, and memory deficits especially in females, mirroring early AD-associated synaptic dysfunction. Together, these findings identify AETA as a novel key contributor of synaptic vulnerability in AD and associated memory processing, especially in females. Targeting AETA signaling may therefore offer new therapeutic avenues for preventing or mitigating synaptic and cognitive decline in AD.

Supplementary Information: The online version contains supplementary material available at 10.1007/s00401-026-03033-2.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Availability of data and materials

All RNA sequencing data generated in this study have been deposited in the Gene Expression Omnibus (GEO) under serie accession number GSE333329 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE333329).

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Publisher: n/a → Springer Science+Business Media

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 17 authors, 5 keywords, 15 MeSH terms, 6 funders, 52 references.

Cite

This paper

Dunot, J., Gandin, C., Truchi, M., Pirro, G., Moreno, S., Launay, A., Azoulay, B., Landra, H., Yishan, S. M., Buée, L., Lebrigand, K., Pousinha, P. A., Blum, D., Mari, B., Bethus, I., Willem, M., & Marie, H. (2026). AETA peptide contributes to Alzheimer's disease signature of synapse dysfunction. Acta neuropathologica, 151(1), 65. https://doi.org/10.1007/s00401-026-03033-2

BibTeX

@article{dunot2026aeta,
author = {Dunot, Jade and Gandin, Carine and Truchi, Marin and Pirro, Giulia and Moreno, Sébastien and Launay, Agathe and Azoulay, Benjamin and Landra, Hugo and Yishan, Sandy Ma and Buée, Luc and Lebrigand, Kevin and Pousinha, Paula A. and Blum, David and Mari, Bernard and Bethus, Ingrid and Willem, Michael and Marie, Hélène},
title = {{AETA peptide contributes to Alzheimer's disease signature of synapse dysfunction}},
journal = {Acta neuropathologica},
year = {2026},
month = jun,
volume = {151},
number = {1},
pages = {65},
publisher = {Springer Science+Business Media},
issn = {0001-6322},
doi = {10.1007/s00401-026-03033-2},
url = {https://doi.org/10.1007/s00401-026-03033-2},
pmid = {42237024},
pmcid = {PMC13233929}
}

RIS

TY - JOUR
AU - Dunot, Jade
AU - Gandin, Carine
AU - Truchi, Marin
AU - Pirro, Giulia
AU - Moreno, Sébastien
AU - Launay, Agathe
AU - Azoulay, Benjamin
AU - Landra, Hugo
AU - Yishan, Sandy Ma
AU - Buée, Luc
AU - Lebrigand, Kevin
AU - Pousinha, Paula A.
AU - Blum, David
AU - Mari, Bernard
AU - Bethus, Ingrid
AU - Willem, Michael
AU - Marie, Hélène
TI - AETA peptide contributes to Alzheimer's disease signature of synapse dysfunction
T2 - Acta neuropathologica
J2 - Acta Neuropathol
PY - 2026
DA - 2026/06/03
VL - 151
IS - 1
SP - 65
SN - 0001-6322
PB - Springer Science+Business Media
DO - 10.1007/s00401-026-03033-2
UR - https://doi.org/10.1007/s00401-026-03033-2
LA - en
ER -

CSL-JSON

{
"id": "10.1007/s00401-026-03033-2",
"type": "article-journal",
"title": "AETA peptide contributes to Alzheimer's disease signature of synapse dysfunction",
"container-title": "Acta neuropathologica",
"author": [
{
"family": "Dunot",
"given": "Jade"
},
{
"family": "Gandin",
"given": "Carine"
},
{
"family": "Truchi",
"given": "Marin"
},
{
"family": "Pirro",
"given": "Giulia"
},
{
"family": "Moreno",
"given": "Sébastien"
},
{
"family": "Launay",
"given": "Agathe"
},
{
"family": "Azoulay",
"given": "Benjamin"
},
{
"family": "Landra",
"given": "Hugo"
},
{
"family": "Yishan",
"given": "Sandy Ma"
},
{
"family": "Buée",
"given": "Luc"
},
{
"family": "Lebrigand",
"given": "Kevin"
},
{
"family": "Pousinha",
"given": "Paula A."
},
{
"family": "Blum",
"given": "David"
},
{
"family": "Mari",
"given": "Bernard"
},
{
"family": "Bethus",
"given": "Ingrid"
},
{
"family": "Willem",
"given": "Michael"
},
{
"family": "Marie",
"given": "Hélène"
}
],
"container-title-short": "Acta Neuropathol",
"volume": "151",
"issue": "1",
"page": "65",
"DOI": "10.1007/s00401-026-03033-2",
"PMID": "42237024",
"PMCID": "PMC13233929",
"ISSN": "0001-6322",
"publisher": "Springer Science+Business Media",
"URL": "https://doi.org/10.1007/s00401-026-03033-2",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
3
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s40478-025-02013-z [code]
Temporal transcriptomic changes in the THY-Tau22 mouse model of tauopathy display cell type- and sex-specific differences.
Journal: Acta neuropathologica communications
In common: Alzheimer's / dementia, mouse, cellular / molecular, 2 authors
[2] doi:10.1038/s41420-024-01885-9 [code]
Single cell transcriptome analysis of the THY-Tau22 mouse model of Alzheimer's disease reveals sex-dependent dysregulations.
Journal: Cell death discovery
In common: Alzheimer's / dementia, mouse, cellular / molecular, 2 authors
[3] doi:10.1172/jci165523
Galectin-3 aggravates microglial activation and tau transmission in tauopathy.
Journal: The Journal of clinical investigation
In common: Alzheimer's / dementia, mouse, cellular / molecular, 2 authors
[4] doi:10.1186/s12929-024-01072-z
Neuroprotective effects of intranasal extracellular vesicles from human platelet concentrates supernatants in traumatic brain injury and Parkinson's disease models.
Journal: Journal of biomedical science
In common: mouse, cellular / molecular, 2 authors
[5] doi:10.1063/5.0196553
Proteomics of human platelet lysates and insight from animal studies on platelet protein diffusion to hippocampus upon intranasal administration.
Journal: APL bioengineering
In common: mouse, cellular / molecular, 2 authors
[6] doi:10.3390/nu15214691 [code]
Multi-Omics Data Integration Reveals Sex-Dependent Hippocampal Programming by Maternal High-Fat Diet during Lactation in Adult Mouse Offspring.
Journal: Nutrients
In common: mouse, 2 authors
[7] doi:10.1002/btm2.10360
Neuroprotective activity of a virus-safe nanofiltered human platelet lysate depleted of extracellular vesicles in Parkinson's disease and traumatic brain injury models.
Journal: Bioengineering & translational medicine
In common: mouse, 2 authors
[8] doi:10.1172/jci149371
Caffeine intake exerts dual genome-wide effects on hippocampal metabolism and learning-dependent transcription.
Journal: The Journal of clinical investigation
In common: mouse, 2 authors
[9] doi:10.1007/s00018-022-04397-w
Can the administration of platelet lysates to the brain help treat neurological disorders?
Journal: Cellular and molecular life sciences : CMLS
In common: 2 authors
[10] doi:10.1038/s41467-026-69866-3 [code]
Selective weakening of population-coupled synaptic activity in vivo in a mouse model of amyloid-beta pathology.
Journal: Nature communications
In common: Alzheimer's / dementia, mouse, cellular / molecular, 5 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.